The structural secret behind the world's first life-saving antibiotic

Science · Published 23 October 2026 Swipe more like this →

In short: In 1928, Alexander Fleming discovered a compound that would change medicine forever. But penicillin wasn't widely available for another decade. Understanding how this molecule physically dismantles bacteria reveals the high-stakes arms race between human innovation and bacterial evolution.

The efficacy of penicillin lies in its specific molecular architecture. A side chain, alongside a five-membered thiozolidine ring and a β-lactam ring, defines these molecules. While the ring structures are essential for the drug's antibacterial activity, the side chain is what determines the pharmacological properties and the spectrum of bacteria it can target. Most penicillins used in modern medicine are semi-synthetic derivatives of 6-aminopenicillic acid. The term antibiotic itself has roots in the late 19th century, derived from French words used by Vuillemin to describe substances that harm microorganisms.

The mechanism of action is fundamentally bactericidal. Rather than simply slowing growth, penicillin inhibits bacterial cell wall synthesis. By disrupting the construction of this protective outer layer, the drug causes the bacteria to perish. This process targets the cell wall biosynthesis pathway, one of the four primary modes of action used by antibiotics to combat microorganisms. This method of action is distinct from other antibiotic strategies, such as the inhibition of DNA replication, protein biosynthesis, or folic acid metabolism.

However, this medical triumph faces a growing global crisis: antibiotic resistance. Bacteria have developed sophisticated defense mechanisms that render these drugs ineffective, and this resistance can spread through various routes among bacterial populations. This escalation is driven by multiple factors, including the human misuse of antibiotics across diverse sectors such as human health, agriculture, livestock breeding, and fish farming. The spread of resistance is a multifaceted problem, as previously susceptible bacteria can acquire the ability to survive through various dissemination routes.

To combat this, scientists are exploring innovative alternatives. These include the development of nanoantibiotics, the use of antibiotic adjuvants, the discovery of entirely new antibiotic classes, and the exploration of biological solutions like bacteriophages and botanicals. Researchers are also investigating the potential of antibiotic adjuvants to help mitigate this worsening global challenge.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

• The decade-long quest to synthesize the world's most famous mold-derived medicine
• How a moldy accident changed the course of human medicine
• The Discovery of Penicillin by Alexander Fleming
• Fleming named penicillin in 1929 for a mould’s antibacterial juice
• From a Sardinian sewer to global medicine: the accidental history of cephalosporin antibiotics
• A new computational tool improves the accuracy of identifying genes in microbes
• Your body's most extensive immune network lives on its surfaces
• New software update expands the search for microbial medicines
• The invisible hitchhikers that thrive at the expense of their hosts
• A new tool improves the identification of diverse microbes in large datasets
• The invisible architecture of life: understanding the three domains
• Diverse alternatives to antibiotics show potential for improving poultry growth and health

More in Microbiology · More in Science · Latest · A–Z · All topics